Altru-CON harnesses proprietary excipient blends and expertise to maximize drug delivery and stability through high-concentration formulation.The platform can reduce IND timelines to under nine ...

Aspire Biopharma’s new sublingual powder bypasses digestion, delivering alprazolam directly for faster anxiety and panic relief.

Phase 3 study designed with total hip BMD primary endpoint assessed at 12 months, rather than at 24 months. EB613 single ...

Bioavailability data recently obtained from Phase 1 study with a stable crystal form of neflamapimod manufactured using a new ...

The global chemical industry is witnessing a significant transition toward high-performance, sustainable additives, as ...

Exciting new human and animal studies designed to enhance business opportunities KELOWNA, BC / ACCESS Newswire / March 4, 2026 / Lexaria Bioscience Corp. (Nasdaq:LEXX), (the "Company" or "Lexaria"), a ...

KIMA CHEMICAL CO., LTD, a prominent global entity in the cellulose derivative sector, has formally announced the successful ...

Kima Chemical Co., Ltd., a prominent manufacturer specializing in cellulose derivatives, has officially confirmed its ...

GLP-1 receptor agonists hold key market opportunities due to their effectiveness in diabetes and obesity management, ...

Ginza Diamond Shiraishi Hong Kong has released an official announcement outlining the craftsmanship framework, material selection principles, and quality control standards behind its Ginza Diamond ...

Company aims to grow the category by appealing to untapped consumer groups with healthier ingredients, unique flavors.